CLERAMARC Trademark

Trademark Overview

On Thursday, October 12, 2017, a trademark application was filed for CLERAMARC with the United States Patent and Trademark Office. The USPTO has given the CLERAMARC trademark a serial number of 87643499. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 31, 2021. This trademark is owned by Pfizer Inc. The CLERAMARC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
cleramarc

General Information

Serial Number87643499
Word MarkCLERAMARC
Filing DateThursday, October 12, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 31, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 27, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 20, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Tuesday, June 1, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 31, 2021ABANDONMENT - NO USE STATEMENT FILED
Friday, September 25, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 24, 2020EXTENSION 5 GRANTED
Wednesday, September 16, 2020EXTENSION 5 FILED
Thursday, September 24, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 16, 2020TEAS EXTENSION RECEIVED
Thursday, March 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 3, 2020EXTENSION 4 GRANTED
Tuesday, March 3, 2020EXTENSION 4 FILED
Tuesday, March 3, 2020TEAS EXTENSION RECEIVED
Monday, March 2, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 2, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 2, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 2, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 2, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 10, 2019EXTENSION 3 GRANTED
Tuesday, September 10, 2019EXTENSION 3 FILED
Tuesday, September 10, 2019TEAS EXTENSION RECEIVED
Tuesday, March 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 8, 2019EXTENSION 2 GRANTED
Friday, March 8, 2019EXTENSION 2 FILED
Friday, March 8, 2019TEAS EXTENSION RECEIVED
Wednesday, October 3, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 1, 2018EXTENSION 1 GRANTED
Monday, October 1, 2018EXTENSION 1 FILED
Monday, October 1, 2018TEAS EXTENSION RECEIVED
Tuesday, April 24, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 27, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 27, 2018PUBLISHED FOR OPPOSITION
Wednesday, February 7, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 23, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 22, 2018ASSIGNED TO EXAMINER
Friday, October 20, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, October 16, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

cleramarc preparations disorders pharmaceutical dysfunction treatment liver erectile blood viral urological